TAG ARCHIVES FOR IRB

10
Mar2021

Bioethical discussion of sharing research findings with participants has proliferated over the last decade. The University of Rochester and Kennedy Krieger Institute are conducting a study that seeks to ascertain stakeholder perspectives on the return of individual research results through qualitative interviews in order to inform decisions related to the return of individual results. Read more

4
Mar2021

On October 15, 2020, PRIM&R hosted a webinar, IRB Operations During a Pandemic. During this webinar, Jeremy N. Block, PhD, MPP; Dorean J. Flores, BS, MPA, CIP; and Hallie Kassan, MS, CIP discussed critical areas of IRB operations during a pandemic, including office, review, and meeting operations; protocol initiation, modification, termination, etc.; protocol operations, and examples of unethical conduct or scandals during the pandemic. Following the webinar, the speakers reflected on the session and attendee feedback. Read more

3
Nov2020

Amid both promising and worrying signs in the development of treatments and vaccines for COVID-19, and in the context of a considerable amount of scrutiny of medical research, some researchers, ethicists, and advocates are working to make sure science doesn’t lose sight of a critical issue: diversity in the clinical trial participant pool. The distribution of research benefits to participants—and the consideration of race in subject selection—is tightly woven into the Belmont Report and has been a mainstay in research ethics discussion ever since. But despite the decades-long consideration of race and ethnicity in clinical trials, many trials still don’t enroll populations that reflect the diversity of the general populace or the group affected by the condition being studied. Read more